We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$56.9B
AUM Growth
+$2.14B
Cap. Flow
-$875M
Cap. Flow %
-1.54%
Top 10 Hldgs %
31.9%
Holding
1,730
New
18
Increased
385
Reduced
488
Closed
24

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$98.8M
2
EL icon
Estee Lauder
EL
+$92.2M
3
NVDA icon
NVIDIA
NVDA
+$83M
4
AMAT icon
Applied Materials
AMAT
+$63.2M
5
AVGO icon
Broadcom
AVGO
+$58.1M

Sector Composition

Rank Sector Weight
1 Technology 30.11%
2 Healthcare 14.35%
3 Financials 12.69%
4 Consumer Discretionary 9.69%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MXL icon
1651
MaxLinear
MXL
$5.21B
$407K ﹤0.01%
28,112
DCH
1652
Dauch Corp
DCH
$1.32B
$407K ﹤0.01%
65,782
CLDT
1653
Chatham Lodging
CLDT
$631M
$405K ﹤0.01%
47,551
LIND icon
1654
Lindblad Expeditions
LIND
$1.87B
$404K ﹤0.01%
43,667
VTOL icon
1655
Bristow Group
VTOL
$1.35B
$402K ﹤0.01%
11,591
RLAY icon
1656
Relay Therapeutics
RLAY
$3.88B
$393K ﹤0.01%
55,450
VSAT icon
1657
Viasat
VSAT
$9.68B
$391K ﹤0.01%
32,766
PACK icon
1658
Ranpak Holdings
PACK
$550M
$387K ﹤0.01%
59,194
LEGN icon
1659
Legend Biotech
LEGN
$3.64B
$383K ﹤0.01%
7,850
BMBL icon
1660
Bumble
BMBL
$386M
$366K ﹤0.01%
57,349
PRTA icon
1661
Prothena Corp
PRTA
$441M
$362K ﹤0.01%
21,643
IART icon
1662
Integra LifeSciences
IART
$1.58B
$362K ﹤0.01%
19,912
ARRY icon
1663
Array Technologies
ARRY
$788M
$360K ﹤0.01%
54,582
IRWD icon
1664
Ironwood Pharmaceuticals
IRWD
$630M
$352K ﹤0.01%
85,392
QFIN icon
1665
Qfin Holdings
QFIN
$1.63B
$331K ﹤0.01%
11,100
GSBC icon
1666
Great Southern Bancorp
GSBC
$877M
$330K ﹤0.01%
5,759
BZ icon
1667
Kanzhun
BZ
$7.09B
$326K ﹤0.01%
18,750
PCRX icon
1668
Pacira BioSciences
PCRX
$1.06B
$316K ﹤0.01%
21,020
SRRK icon
1669
Scholar Rock
SRRK
$5.72B
$312K ﹤0.01%
38,974
MRVI icon
1670
Maravai LifeSciences
MRVI
$1B
$309K ﹤0.01%
37,150
SAGE
1671
DELISTED
Sage Therapeutics
SAGE
$308K ﹤0.01%
42,721
+13,200
+45% +$121K
CNH
1672
CNH Industrial
CNH
$14B
$305K ﹤0.01%
27,450
MEI icon
1673
Methode Electronics
MEI
$498M
$303K ﹤0.01%
25,341
SANA icon
1674
Sana Biotechnology
SANA
$888M
$300K ﹤0.01%
72,050
+4,000
+6% +$21K
WS icon
1675
Worthington Steel
WS
$1.91B
$287K ﹤0.01%
8,450

Similar funds

Ensign Peak Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Ensign Peak Advisors held 1,730 positions worth $56.9B, up 3.9% from $54.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 2.4%. Ensign Peak Advisors opened 18 new positions and exited 24, leaving the 1,730-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q3 2024 buy was Invesco QQQ Trust: 68,400 shares worth $33.4M.
  • Ensign Peak Advisors added most to Oracle in Q3 2024, an estimated $98.8M increase.
  • Ensign Peak Advisors's biggest Q3 2024 reduction was Microsoft, cutting an estimated $122M.
  • Ensign Peak Advisors fully exited Coupang in Q3 2024, selling an estimated $16.3M.
  • Ensign Peak Advisors's ten largest holdings make up 32% of its $56.9B portfolio in Q3 2024.
  • Ensign Peak Advisors opened 18 new positions and closed 24 in Q3 2024.
  • Ensign Peak Advisors's portfolio value rose 3.9% quarter-over-quarter to $56.9B.

Based on Ensign Peak Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.